Last updated at 28 Nov 2024 07:07 PM
Director
DIN: 02644030
Jwalant Sureshbhai Shah is currently associated with 22 companies in various capacities such as Director, CEO, Designated Partner, Whole-time director and Non- Individual Subscriber. They serve as a Director at ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02644030.Jwalant Sureshbhai Shah has previously been associated with 6 companies in roles such as Designated Partner, Additional Director and Director.Jwalant Sureshbhai Shah is currently involved in 5 different roles. Their most recent position is with DR. SANJAY MEHTA UNIPATH SPECIALITY LABORATORY PRIVATE LIMITED as a Non- Individual Subscriber. The first company Jwalant Sureshbhai Shah was appointed to as a director was ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION. Jwalant Sureshbhai Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Jwalant Sureshbhai Shah is currently associated with 22 companies in various capacities such as Director, CEO, Designated Partner, Whole-time director and Non- Individual Subscriber. They serve as a Director at ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 02644030.Jwalant Sureshbhai Shah has previously been associated with 6 companies in roles such as Designated Partner, Additional Director and Director.Jwalant Sureshbhai Shah is currently involved in 5 different roles. Their most recent position is with DR. SANJAY MEHTA UNIPATH SPECIALITY LABORATORY PRIVATE LIMITED as a Non- Individual Subscriber. The first company Jwalant Sureshbhai Shah was appointed to as a director was ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION. Jwalant Sureshbhai Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
24
Male
India
Gain instant access to verified contact details.
Current Companies (6)
Current LLPs (16)
Past Companies (6)
3y 4m 1y 8m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ADVANCED TRANSFUSION MEDICINE RESEARCH FOUNDATION | Director | 21-Aug-2012 |
| UNIPATH SPECIALTY LABORATORY LIMITED | CEO | 01-Feb-2017 |
| UNIPATH SPECIALTY LABORATORY LIMITED | Whole-time director | 01-Apr-2022 |
| SIMIRA UNIPATH DIAGNOSTICS PRIVATE LIMITED | Director | 26-Feb-2024 |
| BIOSCAPE HEALTHSPAN PRIVATE LIMITED | Director | 20-Aug-2024 |
| BIOGRAPH HEALTHSPAN PRIVATE LIMITED | Director | 20-Aug-2024 |
| DR. SANJAY MEHTA UNIPATH SPECIALITY LABORATORY PRIVATE LIMITED | Non- Individual Subscriber | 27-Nov-2024 |
| DR. SANJAY MEHTA UNIPATH SPECIALITY LABORATORY PRIVATE LIMITED | Director | 27-Nov-2024 |